Henry Schein

Henry Schein, Inc. stands as the world's preeminent distributor of healthcare products and services to office-based practitioners, a position built over more than nine decades of continuous growth and innovation. Headquartered in Melville, New York, this Fortune 500 and S&P 500 company operates across 33 countries and territories, serving dental, medical, and veterinary professionals with an unparalleled breadth of products and services. With annual sales reaching $12.7 billion in 2024, Henry Schein has established itself as an indispensable partner to healthcare providers worldwide, maintaining a compound annual growth rate of approximately 11.2% since becoming a public company in 1995.

The company's business model centers on operating as a comprehensive healthcare solutions provider rather than merely a distributor. Through a centralized and automated distribution network, Henry Schein offers a selection of more than 300,000 branded products and Henry Schein private-brand products, backed by sophisticated logistics and value-added technology solutions. The company has strategically organized itself into three reportable segments as of 2024: Global Distribution and Value-Added Services ($10.8 billion in sales), which includes dental and medical distribution plus practice transition, continuing education, consulting, and financial services; Global Specialty Products ($1.4 billion in sales), focusing on specialty healthcare products; and Global Technology ($0.6 billion in sales), providing practice management software and digital solutions that modernize healthcare delivery.

Henry Schein's commitment to ethical business practices has been recognized for 14 consecutive years (2012-2025) as one of the World's Most Ethical Companies by Ethisphere, a distinction that reflects the company's deep-rooted philosophy of "doing well by doing good." This ethical foundation, combined with a unique Team Schein culture that emphasizes integrity, respect, teamwork, and innovation, has enabled the company to navigate complex healthcare landscapes while maintaining strong relationships with manufacturers, healthcare providers, and patients. The company operates through the Henry Schein Cares global corporate citizenship program built on five key pillars, demonstrating that business success and social responsibility can coexist and reinforce one another.

Under the leadership of Stanley M. Bergman, who has served as Chairman and CEO since 1989, Henry Schein has transformed from a small U.S. dental mail-order company with $225 million in revenue into a global healthcare solutions giant approaching $13 billion in annual sales. Bergman's 35-year tenure as CEO—ending with his planned retirement in December 2025 while continuing as Chairman—has been marked by strategic acquisitions, international expansion, and digital transformation. The company's recent strategic initiatives include a major restructuring announced in 2024-2025, a significant investment by KKR, and the launch of the 2025-2027 BOLD+1 Strategic Plan, which positions Henry Schein for continued growth by emphasizing operational efficiency, enhanced customer experience, and expansion in high-margin, high-growth businesses. With strong financial performance including $848 million in operating cash flow for 2024 (up $348 million from 2023) and ambitious 2025 guidance projecting continued earnings growth, Henry Schein remains at the forefront of healthcare distribution and technology innovation.